396 related articles for article (PubMed ID: 26203127)
21. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
Soejima K; Nakagaki T
Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
[TBL] [Abstract][Full Text] [Related]
22. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
23. ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.
Halkidis K; Zheng XL
J Thromb Haemost; 2022 Oct; 20(10):2197-2203. PubMed ID: 35842925
[TBL] [Abstract][Full Text] [Related]
24. The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction.
Austin SK; Starke RD; Lawrie AS; Cohen H; Machin SJ; Mackie IJ
Br J Haematol; 2008 May; 141(4):536-44. PubMed ID: 18341632
[TBL] [Abstract][Full Text] [Related]
25. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model.
Ostertag EM; Bdeir K; Kacir S; Thiboutot M; Gulendran G; Yunk L; Hayes VM; Motto DG; Poncz M; Zheng XL; Cines DB; Siegel DL
Transfusion; 2016 Jul; 56(7):1775-85. PubMed ID: 27040023
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
Matsumoto M; Miyakawa Y; Kokame K; Ueda Y; Wada H; Higasa S; Yagi H; Ogawa Y; Sakai K; Miyata T; Morishita E; Fujimura Y;
Int J Hematol; 2023 Nov; 118(5):529-546. PubMed ID: 37689812
[TBL] [Abstract][Full Text] [Related]
27. Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.
Pillai VG; Bao J; Zander CB; McDaniel JK; Chetty PS; Seeholzer SH; Bdeir K; Cines DB; Zheng XL
Blood; 2016 Jul; 128(1):110-9. PubMed ID: 27207796
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro.
Ostertag EM; Kacir S; Thiboutot M; Gulendran G; Zheng XL; Cines DB; Siegel DL
Transfusion; 2016 Jul; 56(7):1763-74. PubMed ID: 27040144
[TBL] [Abstract][Full Text] [Related]
29. [ADAMTS13, von Willebrand factor specific cleaving protease].
Veyradier A; Coppo P
Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
Lian EC
Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
[TBL] [Abstract][Full Text] [Related]
31. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
32. [Structure and function of ADAMTS13 protease and its relation with diagnosis and treatment of TTP].
Wang Q; Han Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1157-61. PubMed ID: 25130848
[TBL] [Abstract][Full Text] [Related]
33. Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.
Klaus C; Plaimauer B; Studt JD; Dorner F; Lämmle B; Mannucci PM; Scheiflinger F
Blood; 2004 Jun; 103(12):4514-9. PubMed ID: 14976043
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
Shelat SG; Ai J; Zheng XL
Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
[TBL] [Abstract][Full Text] [Related]
35. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.
Jin SY; Skipwith CG; Zheng XL
Blood; 2010 Mar; 115(11):2300-10. PubMed ID: 20075158
[TBL] [Abstract][Full Text] [Related]
36. Analysis on the molecular species and concentration of circulating ADAMTS13 in Blood.
Soejima K; Nakamura H; Hirashima M; Morikawa W; Nozaki C; Nakagaki T
J Biochem; 2006 Jan; 139(1):147-54. PubMed ID: 16428330
[TBL] [Abstract][Full Text] [Related]
37. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions.
Tao Z; Peng Y; Nolasco L; Cal S; Lopez-Otin C; Li R; Moake JL; López JA; Dong JF
Blood; 2005 Dec; 106(13):4139-45. PubMed ID: 16141351
[TBL] [Abstract][Full Text] [Related]
38. Thrombotic thrombocytopenic purpura-what is new?
Shah N; Sarode R
J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
[TBL] [Abstract][Full Text] [Related]
39. Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Roose E; Vidarsson G; Kangro K; Verhagen OJHM; Mancini I; Desender L; Pareyn I; Vandeputte N; Vandenbulcke A; Vendramin C; Schelpe AS; Voorberg J; Azerad MA; Gilardin L; Scully M; Dierickx D; Deckmyn H; De Meyer SF; Peyvandi F; Vanhoorelbeke K
Thromb Haemost; 2018 Oct; 118(10):1729-1742. PubMed ID: 30235483
[TBL] [Abstract][Full Text] [Related]
40. TTP and ADAMTS13: When Is Testing Appropriate?
Mannucci PM; Peyvandi F
Hematology Am Soc Hematol Educ Program; 2007; ():121-6. PubMed ID: 18024619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
